Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 3
1981 9
1982 24
1983 24
1984 7
1985 16
1986 14
1987 27
1988 60
1989 72
1990 92
1991 125
1992 140
1993 168
1994 147
1995 217
1996 240
1997 258
1998 265
1999 281
2000 310
2001 303
2002 252
2003 249
2004 260
2005 210
2006 202
2007 207
2008 186
2009 205
2010 178
2011 180
2012 179
2013 196
2014 158
2015 168
2016 168
2017 175
2018 160
2019 81
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

5,877 results
Results by year
Filters applied: . Clear all
Page 1
Targeting Interleukin-5 or Interleukin-5Rα: Safety Considerations.
Bagnasco D, Ferrando M, Caminati M, Bragantini A, Puggioni F, Varricchi G, Passalacqua G, Canonica GW. Bagnasco D, et al. Drug Saf. 2017 Jul;40(7):559-570. doi: 10.1007/s40264-017-0522-5. Drug Saf. 2017. PMID: 28321782 Review.
Anti-IL5 therapies for asthma.
Farne HA, Wilson A, Powell C, Bax L, Milan SJ. Farne HA, et al. Cochrane Database Syst Rev. 2017 Sep 21;9(9):CD010834. doi: 10.1002/14651858.CD010834.pub3. Cochrane Database Syst Rev. 2017. PMID: 28933516 Free PMC article. Review.
Type 2 immunity in tissue repair and fibrosis.
Gieseck RL 3rd, Wilson MS, Wynn TA. Gieseck RL 3rd, et al. Nat Rev Immunol. 2018 Jan;18(1):62-76. doi: 10.1038/nri.2017.90. Epub 2017 Aug 30. Nat Rev Immunol. 2018. PMID: 28853443 Review.
Anti-interleukin 5 therapy for chronic rhinosinusitis with polyps.
Poblete MJ, Rosenbaum A, Winter M. Poblete MJ, et al. Medwave. 2018 Oct 24;18(6):e7301. doi: 10.5867/medwave.2018.06.7300. Medwave. 2018. PMID: 30365483 Review. English, Spanish.
5,877 results
Jump to page
Feedback